Madrid, Spain – 30 August 2025: Vericiguat reduced the risk of cardiovascular mortality, heart failure (HF) hospitalisations and all-cause mortality across a broad range of patients with HF and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback